Perfil del autor: Otero Candelera, Remedios
Datos institucionales
| Nombre | Otero Candelera, Remedios |
| Departamento | Medicina |
| Área de conocimiento | Medicina |
| Categoría profesional | Profesora Asociada CIS |
| Correo electrónico | Solicitar |
 |
|
Estadísticas
-
Nº publicaciones
22
-
Nº visitas
1524
-
Nº descargas
2887
| Publicaciones |
|---|
Artículo
 Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review
(MDPI, 2022)
Pulmonary hypertension (PH) treatment decisions are driven by the results of randomized controlled trials (RCTs). Subgroup ... |
Artículo
Cellular mechanisms involved in the pathogenesis of airway remodeling in chronic lung disease
(Taylor and Francis LTD, 2022)
Background: Airway epithelial cells and lung fibroblasts play an important role in the develop-ment of chronic lung disease, ... |
Artículo
Biomarkers of venous thromboembolism recurrence after discontinuation of low molecular weight heparin treatment for cancer-associated thrombosis (HISPALIS-study).
(MDPI, 2022)
Abstract: The most appropriate duration of anticoagulant treatment for cancer-associated venous thromboembolism (CAT) ... |
Artículo
Inflammatory response in human lung cells stimulated with plasma from COPD patients
(Biomed Central LTD, 2022)
Background: Chronic obstructive pulmonary disease (COPD) is a condition resulting from a persistent inflammatory state in ... |
Artículo
Cancer – Associated Thrombosis – A Study of Cases
(2021)
Research shows that the presence of cancer increases the likelihood of developing venous thromboembo lism (pulmonary ... |
Tesis Doctoral
Estudio multicéntrico español sobre la seguridad del tratamiento ambulatorio de la embolia pulmonar en el paciente con cáncer
(2021)
La embolia pulmonar (EP) es frecuente en pacientes con cáncer, y constituye una causa de morbilidad y mortalidad relevante ... |
Artículo
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
(WB Saunders CO LTD, 2021)
Objective The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary ... |
Artículo
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
(Elsevier, 2021)
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary ... |
Artículo
Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis
(MDPI, 2021)
Anemia is a common condition in cancer patients and is associated with a wide variety of symptoms that impair quality of ... |
Artículo
Association between preexisting versus newly identified atrial fibrillation and outcomes of patients with acute pulmonary embolism
(American Heart Association, 2021)
Background Atrial fibrillation (AF) may exist before or occur early in the course of pulmonary embolism (PE). We determined ... |
Artículo
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation
(Wiley Online Library, 2021)
Background: The optimal therapy of patients with acute subsegmental pulmonary embolism (PE) is controversial.Methods: We ... |
Artículo
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation A Randomized Clinical Trial
(AMER MEDICAL ASSOCIATION, 2021)
OBJECTIVE To compare usual care plus an active strategy for diagnosing PE with usual care alone in patients hospitalized ... |
Artículo
Systolic blood pressure and mortality in acute symptomatic pulmonary embolism
(Elsevier, 2020)
Background: The optimal cutoff for systolic blood pressure (SBP) level to define high-risk pulmonary embolism (PE) remains ... |
Artículo
Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi
(European Respiratory Society, 2020)
Right heart thrombi portend worse outcomes in pulmonary embolism (PE). In propensity-matched analyses of patients from a ... |
Artículo
Prognostic significance of incidental deep vein thrombosis in patients with cancer presenting with incidental pulmonary embolism
(MDPI, 2020)
In symptomatic acute pulmonary embolism (PE), the presence of deep vein thrombosis (DVT) is a risk factor for 30- and ... |
Artículo
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial
(Oxford University Press, 2020)
Aims: To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute ... |
Artículo
The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease.
(2019)
Introduction: Some previous studies have suggested a high prevalence of pulmonary embolism (PE) during exacerbations of ... |
Tesis Doctoral
Micropartículas circulantes y eventos trombóticos asociados al paciente con cáncer
(2017)
El cáncer lleva a un estado de hipercoagulabilidad debido a una activación aberrante del sistema de coagulación de la ... |
Tesis Doctoral
Caracterización de subpoblaciones de micropartículas en pacientes con enfermedad tromboembólica venosa
(2017)
La enfermedad tromboembólica venosa (ETV) en su expresión trombosis venosa profunda y/o embolia pulmonar es una enfermedad ... |
| Artículo |
Tesis Doctoral
Estudio de seguimiento de pacientes consecutivos diagnosticados de embolismo pulmonar (EP)
(2009)
La enfermedad tromboembólica venosa (ETEV) es una entidad constituida por la trombosis venosa profunda (TVP) y por el ... |
Tesis Doctoral
Seguimiento de la evolución de la gammagrafía pulmonar de perfusión en el tromboembolismo de pulmón
(1992)
Con objeto de conocer la evolución de los defectos de perfusión tras un TEP a los 6, 12 y 18 meses: identificar cuales ... |